Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3%

Zacks

Antares Pharma Inc. (ATRS) saw a big move last session, as the company’s shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $2.85 to $3.16 in the past one-month time frame.

The specialty pharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks and the consensus for loss hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

ATRS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Medical/Dental-Supply industry include Bio-Referance Laboratories Inc. (BRLI), Milestone Scientific Inc. (MLSS) and Steris Corp. (STE). All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>






ANTARES PHARMA INC (ATRS): Free Stock Analysis Report

BIO REFERENCE LABS INC NEW (BRLI): Free Stock Analysis Report

MILESTONE SCIENTIFIC (MLSS): Free Stock Analysis Report

STERIS CORP (STE): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (2)